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 Abstract 
 Syringe exchange is an HIV prevention intervention based on the principles of 
harm reduction. It is intended to prevent the spread of HIV/AIDs and other blood-borne 
infectious diseases amongst injection drug users (IDUs) and their sexual partners.  
Syringe exchange programs (SEPs) accomplish these goals by allowing IDUs to 
exchange used injection equipment for sterile materials.  As a result of their focus on 
prevention in large communities, SEPs meet the definition of a classic public health 
intervention.   Despite this, SEPs are generally met with controversy and funding 
limitations—often at the federal and state levels.  In Washington, DC, SEPs operate 
under the “1000ft rule”, which makes it illegal for any person to distribute needles and/or 
syringes for the injection of any illegal drug in any area within 1000 feet of any school 
(Brady & Fedynyshyn, 2009). The goal of this paper is to review the 1000ft rule and 
provide alternatives to it while alleviating some of the controversy surrounding SEPs.  
 The research methodology employed included a systematic review of journals, 
qualitative interviews, and information available on the World Wide Web. On the basis 
of the information obtained in this review, recommendations for policy change in D.C. 
include: development of a formal stakeholder coalition and educating members on the 
issue; removal of the 1000ft rule from the D.C. code; maximizing access to sterile 
injection materials; and packaging SEPs with other services such as opiod substitution 
therapy, antiretroviral drugs, or talk therapy, to make the intervention more palatable to 
opponents. 
 This paper presents several areas that should be considered for further research 
including more in depth strategies for repealing the 1000ft rule, inclusion of more expert 
ideas for alternatives, and exploration of what has been successful in other jurisdictions 
facing similar challenges with implementation and garnering support of SEPs. All 
community based organizations (CBOs) providing syringe exchange services should be 
solicited for their input.  Evaluation of the effectiveness of SEPs at reducing HIV 
incidence amongst D.C.‟s population of IDUs must be conducted and the data must be 
shared with the greater community as soon as possible.  
  
 Acronym List 
Acquired Immunodeficiency Syndrome AIDS 
Community Based Organization  CBO 
Centers for Disease Control and Prevention CDC 
D.C. Metropolitan Police Department MPD 
Family and Medical Counseling Services FMCS 
Gay Men‟s Health Crisis GMHC 
Helping Individual Prostitutes Survive HIPS 
Human Immunodeficiency Virus HIV 
HIV/AIDS Administration* HAA 
HIV/AIDS, Hepatitis, STD, and TB 
Administration*  
HAHSTA 
Injection Drug User  IDU 
Joint United Nations Programme on 
HIV/AIDS 
UNAIDS 
PreventionWorks! PW 
Public Health Agency of Canada PHAC 
Sexually Transmitted Disease STD 
Substance Abuse and Mental Health Services 
Administration 
SAMHSA 
Syringe Exchange Program SEP 
Tuberculosis TB 
 
*Note: Prior to being known as HAHSTA, this agency was previously identified as HAA until it was 
merged with other branches of the D.C. Department of Health between 2008 and 2009.  
 1 
 
Introduction 
 Over 600,000 Americans have died of AIDS since the early 1980‟s. One-
third of these deaths have been associated with injection drug use (Playing a 
Deadly Game With AIDS, 2009).  Paraphrased from the Public Health Agency of 
Canada, injection drug use is: „the consumption of drugs by injection with a 
needle and syringe. Injection may be intramuscular, subcutaneous, or more 
commonly, intravenous. Intravenous injection creates faster delivery of the drug 
effect and causes less local tissue damage‟ (PHAC, 2007).  Injection drug use 
leads to HIV/AIDS infection when HIV positive users share needles with others.  
In the 40 states participating in confidential, name-based, HIV testing, injection 
drug users (IDUs) accounted for 9% of all new HIV infections.   When reviewing 
diagnoses of AIDS in 2009, it is reported that 14% of cases in the United States 
(US) and the District of Columbia (D.C.) can be attributed to IDU, with African-
Americans and women representing the majority (CDC, 2009; National Center for 
HIV/AIDS, 2008).  Fifty to 90% of all HIV positive IDUs are co-infected with 
Hepatitis C virus (Sulkowski & Thomas, 2003).  Risk behaviors for IDUs involve 
using needles that the user suspects (or knows) may have previously been used 
by another IDU.  This is particularly disconcerting as only 29% of IDUs disinfect 
needles with bleach prior to use (SAMHSA, 2009).  Persons infected through 
injection drug use are more likely to progress to AIDS within twelve months of 
testing positive for HIV than persons in other HIV-positive subgroups.  This is 
possibly due to lower testing rates, late testers/delays in accessing care, or 
inadequate care amongst IDUs (Grigoryan, Hall, Durant, & Wei, 2009; HAHSTA, 
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2010). Syringe exchange programs (SEPs) link IDUs to care and may reduce this 
progression rate. 
 Syringe exchange is a harm reduction intervention in which IDUs who are 
clients of SEPs may exchange used injection equipment for sterile materials.  
The goal of harm reduction is “the prevention of collateral health and social 
damage associated with drug use and limitation of the other medical conditions 
that rampant and poorly treated addictions foster” (Drucker & Clear, 1999).  One 
of these prevented medical conditions is HIV/AIDS.  Syringe exchange programs 
do not provide drugs to clients, but rather prevent the spread of HIV by removing 
contaminated syringes from the streets, reducing needle sharing, and 
encouraging the use of clean syringes for each injection.  These programs do all 
of this while providing vital health and medical services such as condom 
distribution; hepatitis education and testing; HIV counseling, testing, and referral; 
STD screening; tuberculosis (TB) screening; overdose prevention; and safer sex 
education.  SEPs may also provide clients with referrals to other agencies to 
receive services the initial intake agency may not provide (Drucker, Lurie, 
Wodakt, & Alcabes, 1998; Laufer, 2001). Together, the components of SEPs 
make them a classic public health intervention in that these programs have 
preventative components as well as health education aspects that are directed at 
the community level.  
 SEPs are vital because during an average time period of 23.5 days, a 
syringe may be re-used more than seven times when there is no exchange 
available.  This fact is important as studies have shown that HIV-1 remains viable 
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in contaminated syringes for up to 30 days.  Localities with SEPs saw the 
average lifetime of a used syringe drop from 23.5 to under three days (Laufer, 
2001).  Jurisdictions that support SEPs have lower rates of HIV amongst IDUs 
than those that do not, and experience a safer environment as less used 
syringes are improperly discarded in public areas (CDC, 2005; GMHC, 2009; 
Laufer, 2001).  Communities must remember that contracting HIV through a 
contaminated syringe is not an “IDU problem”.  Sexual partners of IDUs (who 
may or may not be users), and their unborn children are also at risk of 
contracting the disease (Playing a Deadly Game With AIDS, 2009).  By 
improving the microenvironment, this public health intervention also protects the 
health of community members using public areas for recreation.   
 In an analysis of SEP in NYC, researchers found SEPs to be cost-
effective as compared to the cost of HIV treatment.  According to this study, 
seven SEPs in NYC spent $20,947 per each HIV infection prevented (assuming 
87 avoided infections for this population), saving nearly $17million in treatment 
costs for the same 87 infections, had they not been prevented—the cost of a 
syringe is minute in comparison to the costs associated with a lifetime of HIV 
treatment (Laufer, 2001).   Although syringe exchange is more cost effective than 
treating HIV/AIDS, the programs do require resources to provide services in their 
communities. The provision of funding is necessary for SEP success, however, 
as discussed further in the “Current Policy” section, we will see that conditional 
funding may harm a community, even when it is intended to support an 
intervention such as syringe exchange.  Syringe exchange funding conditions 
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and regulations vary across jurisdictions, impacting where and how each city 
may operate its programs.  This paper includes a review of the policy, related 
issues, and suggestions for a modified policy.  
Syringe Exchange—The Issue 
 Numerous articles have been published that prove the effectiveness of 
SEPs in reducing the incidence of HIV.  A review by Drucker et al. of all the 
available research at the time, found that the presence of SEPs does not 
correlate with an increase in drug use at the individual or at the community level.  
The literature shows that SEPs help to reduce HIV rates by influencing the 
behavior of IDUs (i.e., sharing needles less often, decreasing the number of 
injections, increasing the mean age of users) and by taking contaminated 
needles off of the street.  Many of these studies have found that IDUs who do not 
participate in SEPs are more likely to contract HIV than those that are SEP 
clients (Drucker, et al., 1998).   
Despite the astounding evidence in support of the effectiveness of syringe 
exchange, it is not an intervention that exists without controversy.  Some 
predominately African-American New York City drug and AIDS treatment 
agencies have argued that SEPs are tantamount to genocide.  This opinion 
stems from the thought that SEPs allegedly give people the means to kill 
themselves via drug abuse (Drucker & Clear, 1999).  This is particularly troubling 
as African-Americans are at higher risk at contracting the virus through injection 
drug use than other ethnic groups (HAHSTA, 2010).  A Georgia republican was 
once quoted saying that “There is no evidence whatsoever that providing addicts 
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an easy way (to inject themselves) with deadly mind altering drugs is diminished 
or reduced by providing them the means to inject deadly mind altering 
substances…” which is of course, true, as the aim of SEPs is to decrease the 
spread of HIV, not to decrease drug use (Drucker & Clear, 1999).  These 
opponents often insist that even sterile needles are dangerous, particularly to 
those who succumb to overdose (Kane, 2010).   Other common arguments 
against SEPs suggest that they are influencing children to use drugs and that 
these programs make it harder to protect them from drug use, suggesting that 
SEPs are a gateway to drug legalization, and that they condone the use of drugs 
(Drucker & Clear, 1999).   
America has a strong tendency towards an abstinence only approach to 
drug treatment, leading to the creation and enforcement of punitive drug laws 
that do not support SEPs and thusly, further the HIV/AIDS epidemic.    Laws 
leading to intense police surveillance of SEPs have been shown to be 
detrimental to program success, in that clients are less likely to access services.  
This is particularly true in the African-American community—program use 
decreased twice as much amongst this IDU sub-population as it did for white 
IDUs during a time of increased police surveillance of an SEP (Davis, Burris, 
Kraut-Becher, Lynch, & Metzger, 2005).  For these reasons, many SEP experts 
teach that increased police activity should never be employed as a measure to 
“scare people straight”, crackdown on IDUs, or harass their clients—IDUs need 
continued support until they are ready to seek treatment options (Katel, 2006).  
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By reviewing the history of SEP and methadone clinic policy development 
in the US, one obtains an understanding of the current state of SEP policy in 
America and the associated challenges with establishing and maintaining SEPs.  
These policies shed light on the fact that the United States prioritizes ending illicit 
drug use over preventing the spread of diseases such as HIV (Drucker & Clear, 
1999).  Although the US pioneered the use of methadone as a heroine 
maintenance intervention (using methadone to wean IDUs off of heroine without 
the symptoms of withdrawal), the growing popularity of rehabilitation centers 
which champion complete drug withdrawal as the only treatment option 
demonizes the use of methadone as drug treatment, as well as stigmatizes IDUs 
and SEPs (Drucker & Clear, 1999).    This strict abstinence only view and its 
associated policies have devastating health consequences for users who are not 
ready to cease using drugs as well as for those who have tried to quit 
unsuccessfully.  Although it has been found that heroin addicts in methadone 
treatment engage in injection drug use associated risk behaviors less often, more 
than 80% of IDUs relapse after ceasing methadone—once again increasing their 
risk of contracting HIV, the virus that causes AIDS (Drucker, et al., 1998). 
 Syringe exchange advocates must counter these arguments with data and 
examples from their experiences in the field.  SEPs have garnered support from 
several law enforcement agencies because they protect officers from accidental 
needle sticks while on the job and reduce the number of contaminated needles in 
communities (amfAR, 2009).  It has been proven that youth in neighborhoods 
with SEPs are not more likely to participate in illicit drug use because of the 
 7 
presence of an SEP and also benefit from having parks and playgrounds where 
there are not used syringes lying about (amfAR, 2009; Bluthenthal, 2009).  
Additionally, many IDUs desire to enter drug treatment but may be on a waiting 
list, may not be fully prepared to enter treatment, or may reside in a community 
that is underserved by drug treatment facilities.   Despite the controversy and 
complexities surrounding SEPs, it is important to remember that the primary 
focus of SEPs is to prevent the spread of HIV/AIDS in high-risk areas.  SEPs do 
this work by providing vital health services IDUs might not otherwise receive, and 
without encouraging drug use, all while being underfunded and with restrictions 
that make their work unduly challenging (Bluthenthal, 2009; CDC, 2010b) 
Current Policy and the ‘1000ft Rule’ 
  As discussed previously, much of the explanation for the current policy 
correlates with the opinions and perspectives of members of Congress who are 
opposed to this intervention (Cooper 2000).   Members of Congress who are not 
strong supporters of SEPs have instated a policy known as the “1000ft rule” in 
D.C.  As stated in the D.C. Code, the 1000ft rule makes it illegal for any person to 
distribute any needle or syringe for the injection of any illegal drug in any area of 
the District that is within 1000 feet of a public or private elementary or secondary 
school, including public charter schools (Brady & Fedynyshyn, 2009).  To many 
SEP advocates and community members, the 1000ft rule is believed to be 
representative of a general discomfort of the federal government towards 
interventions that address diseases with a great amount of stigma. D.C. Council 
member David Catania has spoken out in favor of SEP, stating that the 1000ft 
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restriction will “kill needle exchange in D.C.” (Sticking Point- Congress could end 
the ban on federal funding of needle exchange programs -- and still kill DC's vital 
effort, 2009).  D.C. is a city of only 68.25 square miles, with numerous schools 
throughout.  The 1000ft restriction severely limits where SEPs may operate.  
A comprehensive look at how policies and laws such as the 1000ft rule 
impact how people use drugs is necessary in order to develop the foundation for 
D.C. policy suggestions.  Policies that allow for the operation of SEPs help users 
to inject more safely, preventing many cases of HIV.  Depending on how 
possession laws are crafted, IDUs may be penalized for participation in SEPs, or 
they may be more favorably allowed to access the intervention without police 
interception (Burris, Strathdee, & Vernick, 2002).  Paola Barahona, who has 
been engaged in SEP in D.C. for over a decade, authored a document that 
provides a summative legislative history of SEP in the U.S. and D.C. (Barahona, 
2010).  In 1988 the federal government banned the use of federal funding in 
support of SEPs nationally.  In  1998, after the provision of evidence 
demonstrating the positive impact of SEPs, the federal funding ban remained in 
place, but local jurisdictions were permitted to fund SEPs with local tax dollars, if 
they choose to do so (Barahona, 2010).  Although the rest of the country was 
free to use local tax dollars to fund SEPs, Congress had imposed a ban on using 
local funding for SEP in D.C. through an addition to the D.C. Appropriation, or 
budget (Barahona, 2010).  During this time, SEPs in D.C. depended upon 
charitable donations from private sources.  In 2000, operation of SEPs in D.C. 
became more onerous as language was added to the D.C. budget restriction that 
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included the 1000ft rule.  Later, in 2001 the budget restriction for 1000ft rule 
became D.C. law—no longer requiring yearly inclusion in the city‟s budget.  In 
2007, the local funding ban was lifted in D.C. and programs were allowed local 
tax dollars to support SEPs. In 2009, the ban on federal funding was lifted and 
indicates that federal funds cannot be used in locations “that [have] been 
determined by the local public health or law enforcement authority to be 
inappropriate for such distribution” (CDC, 2010a).  Despite this federal law, in 
D.C., Congress has significant power over how local funding is used, and the 
1000ft rule has remained local law (Barahona, 2010).   
Table 1: Summary of “U.S. Syringe Exchange Policy Overview”  
Source: Barahona, 2010 
 
To compare how other jurisdictions have implemented SEPs in light of the 
removal of the federal funding ban, a review of SEP location regulation in 19 U.S. 
cities was conducted.  Researchers found that the majority (10) of these cities 
have no formal rules governing SEPs sites. Seven have laws/regulations/policies 
concerning SEP locations and others give community based organizations 
(CBOs) the flexibility to operate SEPs in areas where they are most needed, 
Summary Timeline of SEP Funding Nationally & in Washington, DC  
1988 Federal Government banned  the use of federal funding in support of 
SEPs  
1998 Evidence supports positive impact of SEPs on HIV epidemic & is provided 
to Congress 
 All jurisdictions allowed to use local funding to support SEPs, except D.C. 
 PreventionWorks! (D.C.‟s only SEP at the time) began operating using 
private donations 
2001 1000ft rule introduced to D.C. yearly appropriation 
2001 1000ft rule becomes D.C. law 
2007 Local funding ban lifted in D.C. 
2009 Federal funding ban on SEPs lifted  
 10 
without restriction, while others require some form of community consultation 
prior to determining a site for syringe exchange (Burris, Anderson, Case, & 
Davis).  Many of these cities can be used as models for SEP implementation in 
D.C. 
Purpose and Methodology 
 The purpose of this paper is to analyze the current SEP policy in 
Washington, DC and to present a proposal for modifications to the 1000ft rule.  
The methodology to address this goal included a systematic review of the 
literature conducted between September 2010 and February 2011. In this review, 
the following search terms were explored: effect of 1000 foot rule needle 
exchange DC; needle exchange program policy; needle exchange program 
policy (evaluation OR effective OR effectiveness); needle exchange; and needle 
exchange HIV. The following databases were searched: Google Scholar, 
PubMed, Web of Science (ISI), CQ Researcher, and the New York Academy 
Grey Literature Report. In addition to journal articles and publications found from 
these sources, an array of unpublished sources with information specific to the 
District of Columbia that documents the history of syringe exchange in the city as 
well as identifies key players in the development of the current policy.  
Additionally, individuals closely involved with policy development and/or syringe 
exchange in D.C. were contacted for interviews and data was collected from 
various sources available on the World Wide Web.   
  Much of the research needed to support this document was conducted as 
part of the practicum experience at the DC Appleseed Center, under the 
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guidance of Paola Barahona, MPH. DC Appleseed is a public interest advocacy 
organization that researches, reports, and monitors numerous issues of 
importance to the District of Columbia. In 2005, DC Appleseed issued the report 
HIV/AIDS in the Nation’s Capital: Improving the District of Columbia’s Response 
to a Public Health Crisis (Appleseed, 2005).  This 130-page report was the first 
document from Appleseed that assessed the District‟s response to the HIV 
epidemic and made recommendations for improvements.  Since the first report, 
Appleseed has released six report cards, which grade various aspects of D.C.‟s 
response to the epidemic.  The Fourth through Sixth Report Cards discuss SEP 
in D.C.—progress that has been made in providing this intervention, and 
suggestions for improvement (Appleseed, 2008, 2009, 2011). 
  As a second phase of the methodology for this policy analysis a series of 
interviews were conducted. The purpose of these interviews was to take the 
initial steps to broad stakeholder engagement. In attempting to contact persons 
with varying roles in, and perspectives about, syringe exchange, the intent was to 
develop the foundation for inclusive discussions regarding changing the 1000ft 
rule.  Representatives from Helping Individual Prostitutes Survive (HIPS); Bread 
for the City; Family Medical Counseling Services (FMCS); and PreventionWorks! 
(PW) (all SEP providers in D.C.) as well as, HIV/AIDS Hepatitis, STD, 
Tuberculosis, and Syphilis Administration (HAHSTA); the DC Metropolitan Police 
Department (MPD); and the North Carolina Justice Center were contacted.  
Interviews were successfully scheduled and conducted with Adam Searing, JD, 
MPH, Project Director of the Health Access Coalition of the NC Justice Center 
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(personal communication, December 15, 2010); Nestor Rocha, Bureau Chief of 
Prevention & Intervention Services, HAHSTA (personal communication, January 
10, 2011); and Mary Beth Levin, Director of Programs and Services, PW 
(personal communication, January 24, 2011). Sergeant Raul Mendez of the MPD 
replied to the inquiry via email stating that it would not be possible to speak with 
a representative from MPD on this issue, but did provide a link that he believed 
established proof that there was no restriction in D.C. (R. Mendez, personal 
communication, February 15, 2011).  All interviews were conducted with the 
approval of the UNC Chapel Hill IRB under study no. 10-1673. Each interviewee 
was asked the same basic questions, with additional questions asked as 
appropriate, depending upon their responses: 
1) Describe the 1000ft rule as you understand it. 
2) What would you suggest as a method to having the law repealed? 
3) What stakeholders would you involve? 
4) What other suggestions would you like to add? 
 
Many of the suggestions provided by these individuals will be discussed in detail 
in the alternative section and included in the suggestions for further research. 
Common threads found in the interviews include: 
 broad stakeholder involvement in working to spread the availability of 
syringe exchange;  
 involving HIV specialists/physicians in advocacy work;  
 and giving local authorities sole power to make decisions regarding SEP 
locations in D.C.    
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HIV/AIDS & Injection Drug Use in Washington, DC 
 Of all persons living in the District, 3.2% are living with HIV/AIDS, more 
than three times what the Joint United Nations Programme on HIV/AIDS 
(UNAIDS) and the Centers for Disease Control and Prevention (CDC) define as a 
“high prevalence epidemic” (HAHSTA, 2010).  In 2006, 9% of new HIV cases and 
19% of all AIDS cases in D.C. were attributed to injection drug use.  In the five-
year period from 2001-2006, 13% of all new HIV cases were attributed to 
injection drug use (HAA, 2007).  In the period from 2004-2008, 21.4% of new 
AIDS cases were attributed to injection drug use.  In 2008, injection drug use was 
the third leading cause of AIDS in men and second leading cause in women. 
Nearly one third of all HIV/AIDS related deaths in D.C. from 2004-2007 were 
attributed to injection drug use (HAHSTA, 2010).  Of all the HIV/AIDS cases 
attributed to injection drug use in D.C. in 2007, nearly 94% were African-
Americans (HAA, 2008).  Statistics such are these are particularly important in 
D.C. where 54% of residents are African-American (U.S. Census, 2010).  To 
address these data it is imperative that D.C. has a strong policy in support of 
SEPs in place.   
Strengths and Weaknesses of the Current SEP Policy in D.C.  
 Before we consider alternatives to the current policy in D.C., we should 
identify the strengths in the current program that we wish to maintain.  Despite 
challenges presented by the 1000ft rule, there is notable strength in the ways 
CBOs in D.C. have executed the syringe exchange intervention.  PW, the first 
SEP in D.C., which closed its doors in February 2011, intentionally employed ex-
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IDUs (Directors, 2011; Gerson, 2009; Kerr et al., 2010; Terry, 2009).  Using a 
peer-run model facilitates building relationships with the most difficult to reach 
IDUs as well as with maintaining client contact (Gerson, 2009; Kerr, et al., 2010).  
Additionally, such a model may create job opportunities for users who may 
otherwise have difficulty finding viable employment options.   
 A second strength that D.C. has working in its favor is a seeming 
willingness for law enforcement to work with local SEPs to prevent the spread of 
HIV/AIDS in the city.  During conversation with the former Director of Programs & 
Services at PW, Ms. Mary Beth Levin, she stated that as of late, the restriction 
has not been incredibly onerous—law enforcement has been helpful and 
cooperative—when police officers are aware of high injection drug use activity in 
a given area, they have been known to tell SEP staff and suggest they go 
provide services in those areas.  PW has also found that local high schools have 
been helpful, by sending volunteers to work with the program (M. Levin, personal 
communication, January 24, 2011).  These relationships are to be nurtured as full 
community support is required to move forward on implementing policy changes. 
 Lastly, there seems to be a strong sense of interagency collaboration in 
D.C.  Again, per conversation with Mary Beth Levin of PW (personal 
communication, January 24, 2011), organizations work together to support each 
other and clients when there is need. Examples of this include the former 
collaboration between Helping Individual Prostitutes Survive (HIPS) and PW 
which involved sharing and co-training volunteers to ensure that PW volunteers 
are properly educated on issues pertaining to the transgendered population.  PW 
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also trains volunteers at the other programs on topics such as HIV 
testing/counseling, an area which other agencies may not be certified to train.  
PW often refers clients to Bread for the City, which offers free Narcan to its 
clients.  PW staff and clients are referred to FMCS for HIV treatment as well.  
 Of course the current policy is not without weaknesses.  First, the current 
policy and how the legislation was passed can be very confusing.  Before 
changes can be made, stakeholders must be informed about the current policy 
and how it impacts the city.  Secondly, stakeholders must examine the feasibility 
of operating SEPs in the most efficient way under the 1000ft rule. This law should 
be repealed or adjusted in some compromise.  Third, the current policy limits 
access to syringes by requiring “one-for-one” exchanges from its clients. For 
SEPs to have maximum impact, this limitation should be eliminated from SEP 
practices.  Lastly, agencies in D.C. must build upon the current collaboration and 
packaging of services they have now to further the effect SEPs have on HIV 
incidence. 
Suggested Alternatives to the 1000ft Rule and Current SEP Policy in D.C.  
 Based on the strengths and weaknesses of the current policy, many policy 
alternatives need to be considered.  To begin, CBOs and community partners 
must establish a coalition of all relevant stakeholders and educate them on the 
current policy. Education is essential so that all stakeholders are aware of the 
program‟s value (Burris, et al., 2002). A process such as consensus on how to 
address policy issues cannot begin until all stakeholders are well versed on the 
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issue through education on the key issues and possible solutions.   This coalition 
should include:   
 SEP Advocates 
 community members (particularly those uneducated about SEP) 
 law enforcement officers 
 schools 
 D.C. City Council 
 physicians (particularly of IDUs and HIV positive persons) 
 the Mayor‟s office 
 members of Congress 
 and the federal government (particularly the CDC) 
 
The education and input of Congress, D.C. City Council, and the Mayor‟s office 
are essential as they are key to creating the laws that we are to abide by, and 
they ideally represent the interests of the citizenry.  SEP advocates, who are 
probably the best versed on the issue of SEP, will need to take a lead role in the 
education of the community and recruiting others to take part in this important 
work.  Community members must know how SEPs better their communities and 
make informed decisions when giving input regarding SEP locations and 
deciding whether to work with advocates or against them.  Schools, a vital part of 
communities, should be aware of SEP policies, as their proximity to schools is of 
great debate—it is important to hear the voice of the schools as they may have a 
different opinion on the necessary distance than lawmakers, especially as we 
have seen that many students have volunteered with SEPs in the city (M. Levin, 
personal communication, January 24, 2011).  As exemplified in the email 
exchange with the MPD, all stakeholders may not be well versed on the 1000ft 
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rule.  Sergeant Mendez essentially stated that federal law allows localities to 
determine syringe exchange locations with public health and law enforcement but 
stopped short of recognizing that the restriction exists in the D.C. police code—
indicating a lack of understanding of local policy on this issue (R. Mendez, 
personal communication, February 15, 2011).  It is important that members of 
law enforcement know the law so that they do not abuse their power and that 
they protect the rights of all citizens, including IDUs and similarly vulnerable 
populations. Together, these agencies and concerned individuals need to come 
to consensus on how programs can be run most effectively and with minimal 
federal input—evidence that the authority of local public health and law 
enforcement agencies is respected.   
 After all stakeholders have been educated on the issue, work can begin to 
repeal the federally imposed location restriction.  Members of Congress must 
give D.C. the same jurisdictional discretion afforded other localities.  Unrestricting 
locations ensures that programs can reach the most at-risk populations (Wood et 
al., 2002).  According to the agency HIPS, the current location restriction 
presents a difficulty with finding locations to conduct exchanges.  Typically, HIPS 
identifies areas where services are needed by word-of-mouth and by reviewing 
police arrest reports; unfortunately, they have found that high-need areas are 
often near schools (Terry, 2009).  
 While elimination of the location restriction promises to be the most 
meaningful change, according to advocates in D.C., lawmakers may be more 
willing to consider a distance shorter than 1000ft (such as 300ft).  After a trial 
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period of 2-3 years, lawmakers could agree to evaluate program success at 
reducing the HIV rate and any associated neighborhood impact to determine 
feasibility of removing all distance restrictions and allowing communities to 
determine SEP locations. The evaluation should include community members, 
SEP clients, and law enforcement.   
 Evidence suggests that widespread syringe access may decrease HIV 
rates far better than restrictive policies that limit access to and distribution of 
syringes (Kerr, et al., 2010). The third set of recommendations to improve 
success at combating the HIV epidemic involves increasing access to clean 
syringes.  HAHSTA must increase funding levels allocated to SEPs in D.C. and 
allow clients to obtain sterile syringes regardless of the number they return 
(Appleseed, 2009). These goals can be met in part with the use of federal funds 
to support SEPs, in addition to local funds (currently the only source of funding 
used for SEPs in the city) (Appleseed, 2011). Deregulating the sale of syringes 
and decriminalizing possession of syringes that have only trace amounts of drugs 
go hand-in-hand with increasing access to syringes.  In areas underserved by 
SEPs, users may keep syringes to re-use for themselves. This is not the best 
solution, but is a better solution than needle sharing, although, with increased 
police surveillance, can be difficult to implement. Decriminalization also ensures 
that participants are not harassed as they take used syringes to SEPS in order to 
obtain sterile equipment (Burris, et al., 2002; The facts about syringe exchange 
programs (SEPs) and the "1000 foot rule", 2009).   
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 Lastly, it is strongly recommended that strategies for reducing HIV 
incidence amongst IDUs in D.C. be packaged.  When various strategies are 
already employed by SEPs, it is important that they market all facets of the 
program, ensuring the public is aware that the intervention is as comprehensive 
as possible, making their value more evident (Burris, et al., 2002).  Services that 
should be considered in addition to the base intervention of syringe exchange 
(and the services generally provided such as safer sex education, condoms, and 
referrals to drug treatment centers) include the provision of opioid substitution 
therapy (OST), provision of antiretroviral therapy (ART) to known positive IDUs, 
and linkages to family therapy and/or support groups as appropriate for each 
given client (Degenhardt et al., 2010); (Wood, et al., 2002).  Packaging services 
may take some of the unwanted focus away from syringe exchange by way of 
highlighting the other important ways SEPs can help the community.  With the 
closing of PW at the conclusion of February 2011, CBOs and HAHSTA will have 
to shift the focus to maintaining the same level of service to the IDU population 
even in the absence of a provider.  Agencies must commit to building on the 
strength of current collaborations and remain inclusive of current and former 
IDUs in program implementation and planning.  In the interim, these same 
individuals will need to resolve to diminish the weaknesses of the current policy 
such as fighting to repeal the 1000ft rule, elimination of the one-for-one exchange 
policy, and finding creative ways to reach IDUs in high-risk areas near schools.  
Working towards these goals will help ensure the success of SEPs in reducing 
HIV incidence amongst IDUs.  Changes such as these make the focus more 
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about “public policy giving the District more opportunity to address public health 
issues” (A. Searing, personal communication, December 15, 2010).   
 CDC guidance for SEP implementation should have more concrete 
recommendations for program implementation and administration in support of 
each of these policy alternatives.  Messages on SEP implementation that come 
from this agency must clearly give the power to deliver SEP programs to local 
health departments.  These regulations should allow SEPs to develop and adopt 
best practices as they become known.  Each jurisdiction is held accountable for 
public safety & health of residents—the laws should reflect this.   
Areas for Further Research 
 There is a great deal of sources on the subject of syringe exchange, 
although not as many concerning the 1000ft rule.  This paper is not meant to be 
an extensive review of all available research, but is meant to serve as a starting 
point for discussing alternatives to the 1000ft rule with local public health officials, 
law enforcement, community members, local policy makers, and, because of the 
policy development process in Washington, DC, Congress. There are several 
areas that should be considered for further research including strategies for 
repealing the 1000ft rule, inclusion of more experts for ideas for alternatives, and 
deeper exploration of what has been successful in other jurisdictions facing 
similar challenges.  As a direct result of the time it takes to collect, process, and 
report data, there is currently not information available regarding HIV infection 
rates in the IDU population to compare from the time that the local funding ban 
was lifted in 2007 to the present. As soon as this information is available, it must 
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be utilized in discussions and evaluations regarding making changes to the 
current policy (HAA, 2007).    
 SEPs have lead to decreased HIV incidence amongst IDUs in many other 
jurisdictions, but it is important that Washington, DC develop its own body of 
evidence in support of changing policies that affect its citizens.  Furthermore, as 
stated by HAHSTA in the 2009 Annual Update, ‘researchers must develop 
evidence for determining the scope and scale required of an SEP to create 
significant reduction in HIV incidence in IDUs‟ (HAHSTA, 2010).  Without this 
data, it is not possible to know how much more growth SEPs need to achieve 
maximum effect.  Adding an evaluation component to SEPS will aid HAHSTA 
and CBOs in assessing and improving delivery of this life saving intervention. 
 By reaching out to various stakeholders connected to syringe exchange in 
D.C., the author attempted to include as many perspectives as possible; 
however, many more conversations with additional stakeholders will be critical to 
creating change in the District.  It will be very critical to involve medical providers 
who may be against drug use BUT opposed to the increased costs associated 
with HIV infection and the related loss of life.  These individuals work closely with 
SEP clients, will possess unique insight into strategies that will work with 
reaching this community.  Additionally, connecting with all providers who conduct 
syringe exchanges in D.C., specifically Family and Medical Counseling Services 
and Bread for the City in order to gain their perspectives, especially as they work 
to close the gap left by the closing of Prevention Works.   Any suggestions they 
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have for better servicing the IDU community must be taken into account 
(Directors, 2011; Sun, 2011).   
 OST was referenced as a successful combination approach when used in 
conjunction with syringe exchange.  Further research on access to OST in the 
city and its impact on reduction of injection drug use should be considered to 
determine a feasibility of the success of this approach in the District and should 
most likely be spearheaded by the Addiction Prevention and Recovery 
Administration of the D.C. Department of Health (APRA).  Tacoma, Washington 
is well-known for the success of its Point Defiance AIDS Project SEP programs 
and policies which have resulted in a HIV prevalence of less than 2% amongst 
IDUs (Drucker & Clear, 1999). The first attempt at a city-run SEP in NYC resulted 
in a similar 1000ft provision, which was excluded when SEPs were once again 
supported by the Mayor‟s office in 1991 (Drucker & Clear, 1999).  Advocates and 
community leaders in the District may consider researching the history of 
programs in New York and Tacoma to determine what can be applied in D.C. to 
help increase success of SEPs locally.  
 Lastly, as suggested by Adam Searing (personal communication, 
December 15, 2010), interested stakeholders familiar with D.C. legislation may 
consider exploring whether or not there are other political issues that are 
impacted by similar Congressionally imposed restrictions.  If there are, any 
challenges  created by them on issues unrelated to syringe exchange should be 
highlighted and presented as a part of the packet provided to lobby Congress on 
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creating greater access to syringe exchange (A. Searing, personal 
communication, December 15, 2010). 
Conclusion 
 Syringe exchange improves communities while reducing HIV rates 
amongst IDUs and their sexual partners.  Beyond curbing the spread of 
HIV/AIDS, SEPs have a broader community impact on the quality of life and 
health for all.  For example, improperly disposed syringes impact the public‟s 
health because they potentially put children and officers at risk, as both groups 
frequent sites (such as playgrounds) where syringes are commonly left 
unattended. Although we are not able to prevent injection drug use, syringe 
exchange is one method we can employ to lessen the harm associated with this 
practice.  Infectious diseases that are transmitted through injection drug use not 
only effect IDUs, but also members in the communities where IDUs live, use, 
work, and play.  Developing policies that allow local SEPs to properly saturate 
communities will benefit everyone living, working and playing in Washington, 
DC—simply by acting on the knowledge we have that SEPs have been proven to 
decrease the incidence of HIV amongst the IDU population. 
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